| Robert Korsch, DO | |
|
3500 Franciscan Way Ste 300, Michigan City, IN 46360-0021 | |
| (219) 877-1880 | |
| (219) 877-1661 |
| Full Name | Robert Korsch |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 10 Years |
| Location | 3500 Franciscan Way Ste 300, Michigan City, Indiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1982021317 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | 125065073 (Illinois) | Secondary |
| 208800000X | Urology | 02005691A (Indiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Franciscan St Anthony Health - Michigan City | Michigan city, IN | Hospital |
| Franciscan Health Crown Point | Crown point, IN | Hospital |
| Northwest Health - Porter | Valparaiso, IN | Hospital |
| Franciscan Health Dyer | Dyer, IN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Franciscan Physician Network | 3072790682 | 989 |
| Chesterton Physical Therapy Inc | 3173683984 | 36 |
News Archive
The Society to Improve Diagnosis in Medicine (SIDM) and the Cautious Patient Foundation announced today a collaboration to help patients avoid diagnostic errors in their own care. Diagnostic error, defined as wrong, missed or delayed medical diagnosis, occurs in 10 to 15% of diagnostic encounters, is the largest contributor to medical malpractice claims, and is responsible for 40,000 - 80,000 deaths per year in the United States.
Neurocrine Biosciences, Inc. announced today that they have established a worldwide collaboration with Boehringer Ingelheim to research and develop small molecule GPR119 agonists for the treatment of Type II diabetes and other indications. The companies will work jointly to identify and advance candidates into pre-clinical development. Boehringer Ingelheim is responsible for the global development and commercialization of potential GPR119 agonist products.
There is good evidence that polluted air increases the risk of respiratory problems such as asthma - as well as organ inflammation, worsening of diabetes and other life-threatening conditions.
Premature babies are more likely to survive when they are born in high-level neonatal intensive care units (NICUs) than in hospitals without such facilities, and this benefit is considerably larger than previously reported.
› Verified 8 days ago
| Entity Name | Franciscan Physician Network |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1225327984 PECOS PAC ID: 3072790682 Enrollment ID: O20110608000486 |
News Archive
The Society to Improve Diagnosis in Medicine (SIDM) and the Cautious Patient Foundation announced today a collaboration to help patients avoid diagnostic errors in their own care. Diagnostic error, defined as wrong, missed or delayed medical diagnosis, occurs in 10 to 15% of diagnostic encounters, is the largest contributor to medical malpractice claims, and is responsible for 40,000 - 80,000 deaths per year in the United States.
Neurocrine Biosciences, Inc. announced today that they have established a worldwide collaboration with Boehringer Ingelheim to research and develop small molecule GPR119 agonists for the treatment of Type II diabetes and other indications. The companies will work jointly to identify and advance candidates into pre-clinical development. Boehringer Ingelheim is responsible for the global development and commercialization of potential GPR119 agonist products.
There is good evidence that polluted air increases the risk of respiratory problems such as asthma - as well as organ inflammation, worsening of diabetes and other life-threatening conditions.
Premature babies are more likely to survive when they are born in high-level neonatal intensive care units (NICUs) than in hospitals without such facilities, and this benefit is considerably larger than previously reported.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Robert Korsch, DO Po Box 781076, Detroit, MI 48278-1076 Ph: (317) 528-4800 | Robert Korsch, DO 3500 Franciscan Way Ste 300, Michigan City, IN 46360-0021 Ph: (219) 877-1880 |
News Archive
The Society to Improve Diagnosis in Medicine (SIDM) and the Cautious Patient Foundation announced today a collaboration to help patients avoid diagnostic errors in their own care. Diagnostic error, defined as wrong, missed or delayed medical diagnosis, occurs in 10 to 15% of diagnostic encounters, is the largest contributor to medical malpractice claims, and is responsible for 40,000 - 80,000 deaths per year in the United States.
Neurocrine Biosciences, Inc. announced today that they have established a worldwide collaboration with Boehringer Ingelheim to research and develop small molecule GPR119 agonists for the treatment of Type II diabetes and other indications. The companies will work jointly to identify and advance candidates into pre-clinical development. Boehringer Ingelheim is responsible for the global development and commercialization of potential GPR119 agonist products.
There is good evidence that polluted air increases the risk of respiratory problems such as asthma - as well as organ inflammation, worsening of diabetes and other life-threatening conditions.
Premature babies are more likely to survive when they are born in high-level neonatal intensive care units (NICUs) than in hospitals without such facilities, and this benefit is considerably larger than previously reported.
› Verified 8 days ago
Julia G Garcia, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 3500 Franciscan Way Ste 300, Michigan City, IN 46360 Phone: 219-877-1880 Fax: 219-877-1661 | |
Dr. Carey Bernard Ransone, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 8865 W 400 N Ste 105, Michigan City, IN 46360 Phone: 219-861-8740 Fax: 219-877-1029 |